Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Pediatr Blood Cancer. 2016 Aug 24;64(3):10.1002/pbc.26218. doi: 10.1002/pbc.26218

Figure 1.

Figure 1

Tazemetostat (EPZ-6438) in vivo objective response activity kidney rhabdoid tumor models. A. Kaplan-Meier curves with statistical significance indicated by p-values for EFS of the control (gray) and treated (black) groups. B, median relative tumor volume graphs (center), and C. individual tumor volume graphs (right) are shown for selected lines.